| abstract |
The present invention provides a compound of formula I and the use of this compound for the treatment of central nervous system disorders related to or affected by the histamine-3 receptor. Another object of the present invention is to provide therapeutic methods and pharmaceutical compositions useful for the treatment of central nervous system disorders related to or affected by H3 receptors. The present invention provides an N-benzoylpyrrolidin-3-ylamine or N-benzylpyrrolidin-3-ylamine compound of formula I, or a stereoisomer or pharmaceutically acceptable salt thereof. |